Macrogol 4000 Casen Recordati (Macrogol 4000)

Macrogol 4000 is an osmotic laxative that works within the gastrointestinal tract to ease bowel movements.

• Constipation: softens stool and increases frequency of defecation.
• Functional constipation: provides relief when lifestyle changes have not been effective.
• Opioid‑induced constipation: helps restore regularity in patients receiving opioid therapy.

• Macrogol 4000 exerts its laxative effect by retaining water in the intestinal lumen through osmotic activity. The polymer is poorly absorbed, creating an osmotic gradient that draws water into the bowel, increasing stool volume and softness, which stimulates peristalsis and facilitates the passage of feces.

Macrogol 4000 is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Abdominal bloating: mild distension of the abdomen.
• Flatulence: increased intestinal gas.
• Nausea: feeling of unease in the stomach.
• Diarrhoea: loose stools when dosage is high.
• Electrolyte imbalance: rare mild changes in serum levels.

Serious or Rare Side Effects

• Severe dehydration: marked loss of body fluids.
• Allergic reaction: rash, itching, or swelling.
• Abdominal pain: persistent or severe discomfort.
• Rectal bleeding: uncommon but requires medical attention.

Macrogol 4000 should be used with awareness of certain safety considerations.

• Assess hydration: ensure adequate fluid intake to prevent dehydration.
• Monitor electrolytes: especially in patients with renal or cardiac disease.
• Adjust dose in renal impairment: use the lowest effective amount.
• Use caution in children: pediatric dosing must be prescribed by a clinician.
• Avoid prolonged use without review: long‑term therapy should be evaluated regularly.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Macrogol 4000 may interact with other medications that affect fluid or electrolyte balance.

Major Interactions (Avoid)

• Lithium: increased risk of lithium toxicity due to altered absorption.
• Digoxin: potential for reduced serum levels leading to decreased efficacy.

Moderate Interactions (Monitor Closely)

• Antacids containing magnesium or aluminum: may reduce laxative effectiveness.
• Diuretics: monitor for additive dehydration.
• Other osmotic laxatives: avoid concurrent use to prevent excessive fluid loss.